Log In
Print
BCIQ
Print
Print this Print this
 

AZD-1208, AZD1208

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionPan PIM kinase inhibitor
Molecular Target Pim-1 (PIM1) ; Pim-2 (PIM2)
Mechanism of ActionPIM1 inhibitor; PIM2 inhibitor; PIM3 inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHematologic malignancies
Indication DetailsTreat hematologic malignancies
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today